ALS Therapy Development Institute
GPTKB entity
Statements (63)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:Research_Institute
|
gptkbp:advances |
drug discovery for ALS
|
gptkbp:aims_to |
improve quality of life for ALS patients
|
gptkbp:aims_to_improve |
time to market for ALS therapies
|
gptkbp:collaborates_with |
biotechnology companies
|
gptkbp:conducts |
preclinical studies
|
gptkbp:conducts_research_on |
ALS biomarkers
|
gptkbp:dedicated_to |
finding a cure for ALS
|
gptkbp:develops |
therapeutic strategies for ALS
|
gptkbp:educational_programs |
ALS awareness
|
gptkbp:engages_in |
advocacy for ALS research funding
|
gptkbp:focuses_on |
Amyotrophic Lateral Sclerosis (ALS)
|
gptkbp:founded_in |
gptkb:1999
|
gptkbp:funding |
philanthropic donations
|
gptkbp:grants |
government agencies
|
gptkbp:has_collaborated_with |
international research organizations
|
gptkbp:has_developed |
partnerships with pharmaceutical companies
ALS research databases strategies for ALS drug development therapeutic pipelines for ALS |
gptkbp:has_established |
collaborative research networks
research collaborations with universities |
gptkbp:has_hosted |
gptkb:fundraising_events
|
gptkbp:has_participated_in |
ALS awareness campaigns
|
gptkbp:has_performed_at |
surveys on ALS patient needs
|
gptkbp:has_produced |
educational materials for patients and families
|
gptkbp:has_publications |
clinical trial results
|
gptkbp:has_team |
scientists and researchers
|
gptkbp:hosts |
annual ALS research symposiums
|
https://www.w3.org/2000/01/rdf-schema#label |
ALS Therapy Development Institute
|
gptkbp:is_a |
gptkb:non-profit_organization
leader in ALS therapy development. |
gptkbp:is_a_resource_for |
ALS clinical trials
|
gptkbp:is_active_in |
social media outreach
|
gptkbp:is_aleader_in |
ALS research and development
|
gptkbp:is_engaged_in |
community outreach programs
policy advocacy for ALS funding |
gptkbp:is_focused_on |
translational research
patient-centered research |
gptkbp:is_involved_in |
clinical research training
patient advocacy initiatives biomarker discovery for ALS genetic research related to ALS research on ALS genetics |
gptkbp:is_known_for |
innovative research approaches
|
gptkbp:is_part_of |
global ALS research community
|
gptkbp:is_recognized_by |
ALS advocacy groups
|
gptkbp:is_recognized_for |
its contributions to ALS research
|
gptkbp:is_supported_by |
gptkb:corporate_sponsorships
ALS community |
gptkbp:location |
gptkb:Cambridge,_Massachusetts
|
gptkbp:mission |
accelerate the development of effective treatments for ALS
|
gptkbp:offers |
clinical trials
|
gptkbp:offers_workshops_on |
ALS patient care
ALS research methodologies |
gptkbp:partnership |
academic institutions
|
gptkbp:provides |
patient support services
|
gptkbp:provides_information_on |
ALS treatment options
|
gptkbp:publishes |
research findings
|
gptkbp:utilizes |
patient-derived models
|
gptkbp:bfsParent |
gptkb:ALS
gptkb:amyotrophic_lateral_sclerosis |
gptkbp:bfsLayer |
4
|